Utilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer.
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com